Literature DB >> 18174775

The newly identified hypertensive patient: cost-effective laboratory investigation.

Joel Handler1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18174775      PMCID： PMC8110157          DOI： 10.1111/j.1524-6175.2007.07655.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  22 in total

1.  Resurrection of uric acid as a causal risk factor in essential hypertension.

Authors:  Richard J Johnson; Dan I Feig; Jaime Herrera-Acosta; Duk-Hee Kang
Journal:  Hypertension       Date:  2004-11-22       Impact factor: 10.190

2.  Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

Authors:  Bryan Williams; Peter S Lacy; Simon M Thom; Kennedy Cruickshank; Alice Stanton; David Collier; Alun D Hughes; H Thurston; Michael O'Rourke
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

Review 3.  Clinical practice. Hypertriglyceridemia.

Authors:  John D Brunzell
Journal:  N Engl J Med       Date:  2007-09-06       Impact factor: 91.245

4.  Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT).

Authors:  R H Grimm; S Tillinghast; K Daniels; J D Neaton; S Mascioli; R Crow; M Pritzker; R J Prineas
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

5.  Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study.

Authors: 
Journal:  JAMA       Date:  1977-01-17       Impact factor: 56.272

6.  Improved cardiovascular risk stratification by a simple ECG index in hypertension.

Authors:  Paolo Verdecchia; Fabio Angeli; Gianpaolo Reboldi; Erberto Carluccio; Guglielmo Benemio; Roberto Gattobigio; Claudia Borgioni; Maurizio Bentivoglio; Carlo Porcellati; Giuseppe Ambrosio
Journal:  Am J Hypertens       Date:  2003-08       Impact factor: 2.689

7.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study.

Authors:  W B Kannel; R D Abbott
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

8.  The impact of serum uric acid on cardiovascular outcomes in the LIFE study.

Authors:  Aud Høieggen; Michael H Alderman; Sverre E Kjeldsen; Stevo Julius; Richard B Devereux; Ulf De Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Cong Chen; Björn Dahlöf
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

9.  Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.

Authors:  Thomas J Hoerger; Russell Harris; Katherine A Hicks; Katrina Donahue; Stephen Sorensen; Michael Engelgau
Journal:  Ann Intern Med       Date:  2004-05-04       Impact factor: 25.391

10.  Coronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertension.

Authors:  Victor A Lopez; Stanley S Franklin; Simon Tang; Nathan D Wong
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-06       Impact factor: 3.738
View more
  1 in total

1.  Ten years and counting: the journal of clinical hypertension.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.